NasdaqCM - Nasdaq Real Time Price USD
Abeona Therapeutics Inc. (ABEO)
5.27
-0.22
(-4.01%)
At close: May 9 at 4:00:01 PM EDT
5.31
+0.04
+(0.76%)
After hours: May 9 at 7:38:45 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,025,359 | 11 |
| Sales | 33,000 | 3 |
| Net Shares Purchased (Sold) | 992,359 | 14 |
| Total Insider Shares Held | 3.2M | -- |
| % Net Shares Purchased (Sold) | 45.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SESHADRI VISHWAS Chief Executive Officer | Sale at price 4.78 per share. | Direct | 119,500 | Mar 31, 2025 |
| SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| ZEIHER BERNHARDT G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| CROMBEZ ERIC M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| ALVINO MARK J. Director | Sale at price 5.38 per share. | Direct | 21,520 | Jan 29, 2025 |
| SESHADRI VISHWAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| O'MALLEY BRENDAN M General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| VAZZANO JOSEPH WALTER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| ALVINO MARK J. Director | Sale at price 5.10 per share. | Direct | 20,400 | Jan 21, 2025 |
| SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 26, 2024 |
| ZEIHER BERNHARDT G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
| CROMBEZ ERIC M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
| SILVERSTEIN CHRISTINE BERNI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| ALLAND LEILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| AMOROSO MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| CHARLES FAITH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| WUCHTERL DONALD A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| SESHADRI VISHWAS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| O'MALLEY BRENDAN M General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| ALVINO MARK J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| VAZZANO JOSEPH WALTER Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 8, 2024 |
| ALVINO MARK J. Director | Sale at price 4.51 per share. | Direct | 116,764 | Jun 18, 2024 |
| SILVERSTEIN CHRISTINE BERNI Director | Sale at price 4.51 per share. | Direct | 116,453 | Jun 18, 2024 |
| ALLAND LEILA Director | Purchase at price 4.71 per share. | Direct | 51,799 | May 16, 2024 |
| CHARLES FAITH L. Director | Purchase at price 3.28 per share. | Direct | 24,764 | Apr 26, 2024 |
| SESHADRI VISHWAS Chief Executive Officer | Purchase at price 3.20 per share. | Direct | 32,000 | Apr 25, 2024 |
| O'MALLEY BRENDAN M General Counsel | Purchase at price 3.24 per share. | Direct | 27,864 | Apr 25, 2024 |
| VAZZANO JOSEPH WALTER Chief Financial Officer | Purchase at price 3.14 per share. | Direct | 17,609 | Apr 25, 2024 |
| SESHADRI VISHWAS Chief Executive Officer | Purchase at price 4.39 per share. | Direct | 87,800 | Feb 6, 2024 |
| ALVINO MARK J. Director | Sale at price 5.11 per share. | Direct | 36,199 | Jan 17, 2024 |
| SESHADRI VISHWAS Chief Executive Officer | Purchase at price 4.07 per share. | Direct | 81,400 | Sep 27, 2023 |
| SILVERSTEIN CHRISTINE BERNI Director | Sale at price 3.91 per share. | Direct | 24,721 | Sep 27, 2023 |
| ALLAND LEILA Director | Sale at price 3.90 per share. | Direct | 28,270 | Sep 27, 2023 |
| AMOROSO MICHAEL Director | Sale at price 3.91 per share. | Direct | 21,542 | Sep 27, 2023 |
| CHARLES FAITH L. Director | Sale at price 3.96 per share. | Direct | 32,987 | Sep 27, 2023 |
| ALVINO MARK J. Director | Sale at price 3.91 per share. | Direct | 24,724 | Sep 27, 2023 |
| AMOROSO MICHAEL Director | Sale at price 3.90 per share. | Direct | 1,275 | Sep 20, 2023 |
| VAZZANO JOSEPH WALTER Chief Financial Officer | Purchase at price 3.70 - 3.82 per share. | Direct | 11,458 | Sep 19, 2023 |
| O'MALLEY BRENDAN M General Counsel | Purchase at price 3.80 per share. | Direct | 11,400 | Sep 18, 2023 |
| AMOROSO MICHAEL Director | Sale at price 4.45 per share. | Direct | 1,504 | Jun 20, 2023 |
Related Tickers
MIST Milestone Pharmaceuticals Inc.
1.1100
-7.50%
ALDX Aldeyra Therapeutics, Inc.
2.1800
+0.93%
KRYS Krystal Biotech, Inc.
132.18
-3.64%
RARE Ultragenyx Pharmaceutical Inc.
35.11
-2.42%
URGN UroGen Pharma Ltd.
10.38
-2.72%
CAPR Capricor Therapeutics, Inc.
6.34
-9.04%
ATRA Atara Biotherapeutics, Inc.
7.27
-2.02%
VSTM Verastem, Inc.
7.17
+3.31%
SLNO Soleno Therapeutics, Inc.
76.78
+0.68%
NUVB Nuvation Bio Inc.
2.0900
-0.48%